HPV research

Few teenage girls and young women are getting the cancer-preventing vaccine for human papillomavirus (HPV), and many of those who start the regimen fail to take all three doses, new research reveals. Although studies have shown that the HPV vaccine is safe and effective against several strains of the sexually transmitted virus, just one-third of teens and young women who start the three-dose series actually finish, and almost three-quarters don't start it at all, according to research presented last week at the American Association of Cancer Research annual meeting in Philadelphia.

- HealthDay

What's in store with the weather ... Exploring LI's complex web of transit options ... Out East: Critterville Farm Sanctuary Credit: Newsday

Newsday Investigates: Girl was absent, late in half the school days in months before death ... Families left with uncertainty after Nepal ends flood rescue ... This surprise for a little boy doesn't stink! ... Let's Go: Catskill Mountain Railroad

What's in store with the weather ... Exploring LI's complex web of transit options ... Out East: Critterville Farm Sanctuary Credit: Newsday

Newsday Investigates: Girl was absent, late in half the school days in months before death ... Families left with uncertainty after Nepal ends flood rescue ... This surprise for a little boy doesn't stink! ... Let's Go: Catskill Mountain Railroad

Subscribe

Unlimited Digital AccessOnly 25¢for 6 months

SUBSCRIBESALE ENDS SOON | CANCEL ANYTIME